Psychedelics, such as psilocybin, provide lasting improvements in mood and feelings of social connectedness, after the effect of the drug has worn off.
Study reveals mindfulness-based stress reduction methods proved to be as effective as antidepressants for relieving symptoms for those with anxiety disorders.
4E-BPs proteins are key to unlocking ketamine's antidepressant effects. When 4E-BPs are absent in neurons, ketamine can not produce its antidepressant effect.
A new study will explore how psilocybin affects different networks and serotonin function in the brains of autistic adults.
Researchers are testing a new method that could help find the best anti-depressants for individual patients more efficiently.
Researchers have identified a mechanism that could help explain how ketamine helps relieve symptoms of depression.
A new study reveals over the counter pain killers may negatively influence information processing and emotional response.
Researchers discuss how psychedelics can affect the brain and provide therapeutic benefits for those suffering from a range of psychiatric disorders.
Study reveals a moderate link between antipsychotic use and an increased risk of developing breast cancer.
Medications with anticholinergic properties given to help reduce physical and mental health symptoms associated with schizophrenia have a cumulative effect in reducing cognitive function in patients.
Psilocybin can restore mGluR2 levels in the prefrontal cortex, and this leads to a reduced risk of relapse for those with alcohol use disorder.
Researchers report alcohol can strengthen fearful memories, but a drug used to treat seizures may reverse the effects.
